Maze Therapeutics, Inc. (MAZE) vs Intellia Therapeutics, Inc. (NTLA)
- Maze Therapeutics, Inc. MAZE 27.53 +0.18%
- Intellia Therapeutics, Inc. NTLA 11.42 +0.71%
Maze Therapeutics, Inc. and Intellia Therapeutics, Inc. are both Biotechnology companies. Maze Therapeutics, Inc. and Intellia Therapeutics, Inc. are of similar size ($1.6B and $1.5B). Maze Therapeutics, Inc. has the higher net margin (0.00% vs −672.2%) and the lower return on invested capital (−112.4% vs −91.3%). Across the 13 metrics below, Maze Therapeutics, Inc. leads on 8 and Intellia Therapeutics, Inc. on 5.
Valuation
Profitability
| Metric | MAZE | NTLA | Biotechnology median |
|---|---|---|---|
| Gross margin | — | 100.00% | 65.16% |
| Operating margin | 0.00% | (711.66%) | 0.00% |
| Net margin | 0.00% | (672.16%) | 0.00% |
| Free cash flow margin | 0.00% | (585.82%) | 0.00% |
| Return on equity | (37.35%) | (55.44%) | (56.36%) |
| Return on assets | (31.99%) | (45.55%) | (48.04%) |
| Return on invested capital | (112.36%) | (91.28%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack